195 related articles for article (PubMed ID: 35697509)
1. Introducing genetic testing with case finding for familial hypercholesterolaemia in primary care: qualitative study of patient and health professional experience.
Silva L; Condon L; Qureshi N; Dutton B; Weng S; Kai J
Br J Gen Pract; 2022 Jul; 72(720):e519-e527. PubMed ID: 35697509
[TBL] [Abstract][Full Text] [Related]
2. Case-finding and genetic testing for familial hypercholesterolaemia in primary care.
Qureshi N; Akyea RK; Dutton B; Humphries SE; Abdul Hamid H; Condon L; Weng SF; Kai J;
Heart; 2021 Dec; 107(24):1956-1961. PubMed ID: 34521694
[TBL] [Abstract][Full Text] [Related]
3. Comparing the performance of the novel FAMCAT algorithms and established case-finding criteria for familial hypercholesterolaemia in primary care.
Qureshi N; Akyea RK; Dutton B; Leonardi-Bee J; Humphries SE; Weng S; Kai J
Open Heart; 2021 Oct; 8(2):. PubMed ID: 34635577
[TBL] [Abstract][Full Text] [Related]
4. Participant experiences of intervention to detect and manage familial hypercholesterolaemia in Australian general practice: A qualitative descriptive study.
Skoss R; Brett T; Bulsara C; Radford J; Heal C; Gill G; Hespe C; Vargas-Garcia C; Li IW; Sullivan DR; Vickery AW; Pang J; Arnold-Reed DE; Watts GF
Aust J Gen Pract; 2022 Sep; 51(9):687-694. PubMed ID: 36045626
[TBL] [Abstract][Full Text] [Related]
5. Optimising the detection and management of familial hypercholesterolaemia: central role of primary care and its integration with specialist services.
Vickery AW; Bell D; Garton-Smith J; Kirke AB; Pang J; Watts GF
Heart Lung Circ; 2014 Dec; 23(12):1158-64. PubMed ID: 25130889
[TBL] [Abstract][Full Text] [Related]
6. Screening for familial hypercholesterolaemia in primary care: Time for general practice to play its part.
Brett T; Qureshi N; Gidding S; Watts GF
Atherosclerosis; 2018 Oct; 277():399-406. PubMed ID: 30270077
[TBL] [Abstract][Full Text] [Related]
7. Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis.
Marks D; Wonderling D; Thorogood M; Lambert H; Humphries SE; Neil HA
Health Technol Assess; 2000; 4(29):1-123. PubMed ID: 11109029
[TBL] [Abstract][Full Text] [Related]
8. Can patients be accurately assessed for familial hypercholesterolaemia in primary care?
Bell DA; Kirke AB; Barbour R; Southwell L; Pang J; Burrows S; Watts GF
Heart Lung Circ; 2014 Dec; 23(12):1153-7. PubMed ID: 25065543
[TBL] [Abstract][Full Text] [Related]
9. Improving identification of familial hypercholesterolaemia in primary care: derivation and validation of the familial hypercholesterolaemia case ascertainment tool (FAMCAT).
Weng SF; Kai J; Andrew Neil H; Humphries SE; Qureshi N
Atherosclerosis; 2015 Feb; 238(2):336-43. PubMed ID: 25555265
[TBL] [Abstract][Full Text] [Related]
10. Awareness of familial hypercholesterolaemia in Australian primary care: A qualitative descriptive study.
Bulsara C; Brett T; Radford J; Heal C; Gill G; Hespe CM; Vargas-Garcia C; Li IW; Sullivan DR; Vickery AW; Pang J; Arnold-Reed D; Chan DC; Watts GF
Aust J Gen Pract; 2021 Sep; 50(9):634-640. PubMed ID: 34462767
[TBL] [Abstract][Full Text] [Related]
11. Detection of familial hypercholesterolaemia: external validation of the FAMCAT clinical case-finding algorithm to identify patients in primary care.
Weng S; Kai J; Akyea R; Qureshi N
Lancet Public Health; 2019 May; 4(5):e256-e264. PubMed ID: 31054643
[TBL] [Abstract][Full Text] [Related]
12. Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration.
; Vallejo-Vaz AJ; Akram A; Kondapally Seshasai SR; Cole D; Watts GF; Hovingh GK; Kastelein JJ; Mata P; Raal FJ; Santos RD; Soran H; Freiberger T; Abifadel M; Aguilar-Salinas CA; Alnouri F; Alonso R; Al-Rasadi K; Banach M; Bogsrud MP; Bourbon M; Bruckert E; Car J; Ceska R; Corral P; Descamps O; Dieplinger H; Do CT; Durst R; Ezhov MV; Fras Z; Gaita D; Gaspar IM; Genest J; Harada-Shiba M; Jiang L; Kayikcioglu M; Lam CS; Latkovskis G; Laufs U; Liberopoulos E; Lin J; Lin N; Maher V; Majano N; Marais AD; März W; Mirrakhimov E; Miserez AR; Mitchenko O; Nawawi H; Nilsson L; Nordestgaard BG; Paragh G; Petrulioniene Z; Pojskic B; Reiner Ž; Sahebkar A; Santos LE; Schunkert H; Shehab A; Slimane MN; Stoll M; Su TC; Susekov A; Tilney M; Tomlinson B; Tselepis AD; Vohnout B; Widén E; Yamashita S; Catapano AL; Ray KK
Atheroscler Suppl; 2016 Dec; 22():1-32. PubMed ID: 27939304
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of improving identification of familial hypercholesterolaemia in general practice: intervention development study.
Qureshi N; Weng S; Tranter J; El-Kadiki A; Kai J
BMJ Open; 2016 May; 6(5):e011734. PubMed ID: 27231005
[TBL] [Abstract][Full Text] [Related]
14. Evaluating a clinical tool (FAMCAT) for identifying familial hypercholesterolaemia in primary care: a retrospective cohort study.
Akyea RK; Qureshi N; Kai J; de Lusignan S; Sherlock J; McGee C; Weng S
BJGP Open; 2020 Dec; 4(5):. PubMed ID: 33144363
[TBL] [Abstract][Full Text] [Related]
15. Systematic detection of familial hypercholesterolaemia in primary health care: a community based prospective study of three methods.
Kirke AB; Barbour RA; Burrows S; Bell DA; Vickery AW; Emery J; Watts GF
Heart Lung Circ; 2015 Mar; 24(3):250-6. PubMed ID: 25445428
[TBL] [Abstract][Full Text] [Related]
16. Implementation of a primary-tertiary shared care model to improve the detection of familial hypercholesterolaemia (FH): a mixed methods pre-post implementation study protocol.
Birkenhead K; Sullivan D; Trumble C; Spinks C; Srinivasan S; Partington A; Elias L; Hespe CM; Fleming G; Li S; Calder M; Robertson E; Trent R; Sarkies MN
BMJ Open; 2024 May; 14(5):e082699. PubMed ID: 38692720
[TBL] [Abstract][Full Text] [Related]
17. Cost-utility analysis of searching electronic health records and cascade testing to identify and diagnose familial hypercholesterolaemia in England and Wales.
Crosland P; Maconachie R; Buckner S; McGuire H; Humphries SE; Qureshi N
Atherosclerosis; 2018 Aug; 275():80-87. PubMed ID: 29879685
[TBL] [Abstract][Full Text] [Related]
18. International Atherosclerosis Society Roadmap for Familial Hypercholesterolaemia.
Watts GF; Jones LK; Sarkies MN; Pang J; Gidding SS; Libby P; Santos RD
Glob Heart; 2024; 19(1):12. PubMed ID: 38273993
[TBL] [Abstract][Full Text] [Related]
19. Detection of familial hypercholesterolemia in patients from a general practice database.
Casula M; Catapano AL; Rossi Bernardi L; Visconti M; Aronica A
Atheroscler Suppl; 2017 Oct; 29():25-30. PubMed ID: 28965617
[TBL] [Abstract][Full Text] [Related]
20. Improving identification and management of familial hypercholesterolaemia in primary care: Pre- and post-intervention study.
Weng S; Kai J; Tranter J; Leonardi-Bee J; Qureshi N
Atherosclerosis; 2018 Jul; 274():54-60. PubMed ID: 29751285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
